Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 140.55
-0.481 %
$ 20.5 B
Market Cap
12.72
P/E
BIIB - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities BIIB - Biogen Inc.
149 M
LAST VALUE
43.93%
2 YEAR CAGR
15.25%
5 YEAR CAGR
8.24%
10 YEAR CAGR